| Literature DB >> 27491565 |
Joanne Kwak-Kim1, Annie Skariah2, Li Wu2, Dinorah Salazar2, Nayoung Sung2, Kuniaki Ota3.
Abstract
Women with recurrent pregnancy losses (RPL) and repeated implantation failures (RIF) have auto- and cellular immune abnormalities. Approximately, 20% of women with RPL have autoimmune abnormalities, particularly antiphospholipid antibodies (APA). In addition, these women have a higher prevalence of antinuclear antibody, anti-thyroperoxidase and anti-thyroglobulin antibodies, and other non-organ-specific autoantibodies. In women with RPL, the presence of autoimmunity is often associated with cellular immune abnormalities, such as increased NK cell levels and Th1/Th2 cell ratios. Vitamin D (VD) plays a major role in regulation of auto- and cellular immune abnormalities. VD deficiency is prevalent in women with RPL, and women with VD deficiency have increased auto- and cellular immune abnormalities as compared with women with normal VD levels. VD has immune regulatory effects on various immune effectors including T, B and NK cells. Potential therapeutic application of VD for RPL and RIF with auto- and cellular immune abnormalities should be explored.Entities:
Keywords: Antiphospholipid antibody; Autoimmunity; NK cells; Recurrent pregnancy losses; Repeated implantation failures; Th1/Th2
Mesh:
Substances:
Year: 2016 PMID: 27491565 DOI: 10.1016/j.autrev.2016.07.015
Source DB: PubMed Journal: Autoimmun Rev ISSN: 1568-9972 Impact factor: 9.754